Biotechnology Company
Biotechnology company innovates pharma commercialization engine
Leading biotech gains application integration to support critical commercial processes and leverages partner expertise to launch first drug with OpenText Alloy
The OpenText partnership not only helps to drive the commercial framework for our first RNAi therapeutics product launch, it also establishes a foundation for our broader commercialization efforts.
Challenge
- Integration hurdles to support commercial readiness
- Difficulty aggregating disparate systems to support emerging needs
- Aggressive implementation schedule prior to first product launch
Product(s)
Value
- Enabled critical go-to-market processes for on-time product launch
- Ensured built-in data harmonization, data exchange and analytics capabilities across the business
- Leveraged OpenText expertise, reducing integration complexities and delivering faster time to value
About Biotechnology Company
This biotechnology company is the leading RNAi company on the forefront of this revolutionary approach to patient care. In advance of an FDA approval for the company’s first commercial product, the rapidly growing biotech needed technology and processes to support growth at an accelerated pace as it prepared for launch.